Protocols
1 protocol(s) meet the specified criteria
Drug: Tremelimumab
Protocol No.TitleStatus
D419LC00001A Phase III Randomized, Open-label, Multi-center, Global Study of MEDI4736 Alone or in Combination with Tremelimumab versus Standard of Care in the Treatment of First-line Recurrent or Metastatic Squamous Cell Head and Neck Cancer PatientsOpen